p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
about
Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathwayHuman Cyclin-dependent Kinase 2-associated Protein 1 (CDK2AP1) Is Dimeric in Its Disulfide-reduced State, with Natively Disordered N-terminal RegionTargeted inactivation of p12, CDK2 associating protein 1, leads to early embryonic lethalityOverexpression of DOC-1R inhibits cell cycle G1/S transition by repressing CDK2 expression and activationmiR-21 downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell proliferation and invasion.Mutation of Cys105 inhibits dimerization of p12CDK2-AP1 and its growth suppressor effect.Knockdown of CDK2AP1 in primary human fibroblasts induces p53 dependent senescence.miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.A novel regulatory factor recruits the nucleosome remodeling complex to wingless integrated (Wnt) signaling gene promoters in mouse embryonic stem cellsIL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci.Molecular mechanisms of head and neck cancer.Common variants at 12q15 and 12q24 are associated with infant head circumference.Cyclin-dependent kinase 2-associating protein 1 commits murine embryonic stem cell differentiation through retinoblastoma protein regulation.Structure and function insights into the NuRD chromatin remodeling complex.Clinical aggressiveness of myxofibrosarcomas associates with down-regulation of p12CDK2AP1: prognostic implication of a putative tumor suppressor that induces cell cycle arrest and apoptosis via mitochondrial pathway.Knockdown of CDK2AP1 by RNA interference inhibits cell growth and tumorigenesis of human glioma.p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation.Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms.Cdk2ap1 is required for epigenetic silencing of Oct4 during murine embryonic stem cell differentiation.p12(CDK2-AP1) mediates DNA damage responses induced by cisplatin.Progesterone is primary regulator of Cdk2ap1 gene expression and tissue-specific expression in the uterus.Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth.Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs.Establishment of a sandwich enzyme-linked immunosorbent assay for specific detection of Bacillus thuringiensis (Bt) Cry1Ab toxin utilizing a monoclonal antibody produced with a novel hapten designed with molecular model.Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells.Knockdown of CDK2AP1 in human embryonic stem cells reduces the threshold of differentiation.
P2860
Q24681953-B95A64E1-466C-42F6-908C-2516CF59C977Q27678086-E1A8667E-36FF-488F-AF4C-665C0D5AC9B3Q28512766-1EB4B5BF-BF52-4287-BEED-F2E8318A43AEQ28941776-C864B1D3-43B3-4F64-8CE4-0D85D42CDB29Q34165180-06B56130-D7F4-47F7-AE89-591B0879FFC2Q34412512-740703B8-6604-419E-A743-C12F68E54D3DQ35580422-41D5BDC1-B5D5-4168-93DE-4F81CC30D7BFQ36222725-65F99148-9AC7-45D8-8586-57EB083B7A10Q36436047-0A67846F-17E7-4413-899A-E848664F7763Q36825016-9A411AF9-AC53-4959-8E27-0E47B6793250Q37159537-B0B35161-A84D-41E9-BF2E-BF8D64A0CCC7Q37173595-CAA0435D-4D28-4174-875C-89CBEDAE3655Q37358116-DD0BA499-3EE4-4A12-874B-C2B3AB6D08BCQ38386331-6E6C60A1-72B3-4166-9A6C-6A7CF9132397Q38989078-4F51A3C0-498B-4B47-9357-F3967BFA45A6Q39016317-9B34CD1C-07BD-41AD-BD27-BBAEE73FC451Q39308784-866D2F59-50B0-4F06-983E-AFCC9A156988Q39694172-BE9621B5-4C5B-48D8-9BF2-DE497DBEC69EQ39839773-17C8A2EC-F102-4D05-92F9-A5C26595FCF0Q39899717-D1E96D1F-36DA-43E4-A785-A2AC8F47C907Q40492168-88571718-F2BE-4730-BCD9-E534E163BB95Q43114320-26FA2963-A853-4B46-9A16-CBD9DBC1FFC0Q43225336-CEB43E09-0787-4493-B915-3AE53D5B0F3FQ52719972-28F7E3CF-7DC4-4102-A684-20D515091F37Q52862193-3393CAD3-0E78-4535-BD7F-EF01893B173DQ53302883-96318EE2-E5A4-4C8F-9C16-11BF3BE13107Q54979605-ADFDBED3-7C9D-42AE-8030-83849C9B8210
P2860
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@ast
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@en
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@nl
type
label
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@ast
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@en
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@nl
prefLabel
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@ast
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@en
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@nl
P2093
P2860
P1476
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein
@en
P2093
S Shintani
P2860
P304
P356
10.1128/MCB.20.17.6300-6307.2000
P407
P577
2000-09-01T00:00:00Z